| # | Drug | Count |
|---|---|---|
| 0 | EPINEPHRINE | 24 |
| 1 | METFORMIN | 20 |
| 2 | ONDANSETRON | 20 |
| 3 | ONDANSETRON HYDROCHLORIDE | 20 |
| 4 | PHENYLEPHRINE | 17 |
| 5 | IBUPROFEN | 16 |
| 6 | ACETAMINOPHEN | 15 |
| 7 | METOPROLOL | 15 |
| 8 | METOPROLOL TARTRATE | 15 |
| 9 | BUPIVACAINE HYDROCHLORIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | 1 | 0.0909 |
| 1 | TRACE ELEMENTS INJECTION 4 | 1 | 0.0714 |
| 2 | INSULIN ASPART-XJHZ | 2 | 0.0667 |
| 3 | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0333 |
| 4 | ASPIRIN, ACETAMINOPHEN, CAFFEINE | 1 | 0.0294 |
| 5 | NALOXONE HCL | 13 | 0.0151 |
| 6 | SODIUM ACETATE | 3 | 0.0105 |
| 7 | CHLORPROMAZINE HYDROCHLORIDE | 5 | 0.0052 |
| 8 | SELEGILINE HYDROCHLORIDE | 3 | 0.0051 |
| 9 | LIGHT MINERAL OIL AND MINERAL OIL | 1 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 1 | Insulin Analog [EPC] | 30 |
| 2 | Corticosteroid [EPC] | 29 |
| 3 | Catecholamine [EPC] | 27 |
| 4 | alpha-Adrenergic Agonist [EPC] | 24 |
| 5 | beta-Adrenergic Agonist [EPC] | 24 |
| 6 | Osmotic Laxative [EPC] | 22 |
| 7 | Benzodiazepine [EPC] | 20 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 20 |
| 9 | alpha-1 Adrenergic Agonist [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-1 Adrenergic Agonist [EPC] | 17 | 0.0038 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 4 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 5 | Antifibrinolytic Agent [EPC] | 10 | 0.0010 |
| 6 | Oxytocic [EPC] | 3 | 0.0010 |
| 7 | Adenosine Receptor Agonist [EPC] | 5 | 0.0007 |
| 8 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |